FR2193576A1 - - Google Patents

Info

Publication number
FR2193576A1
FR2193576A1 FR7218035A FR7218035A FR2193576A1 FR 2193576 A1 FR2193576 A1 FR 2193576A1 FR 7218035 A FR7218035 A FR 7218035A FR 7218035 A FR7218035 A FR 7218035A FR 2193576 A1 FR2193576 A1 FR 2193576A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7218035A
Other languages
French (fr)
Other versions
FR2193576B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7218035A priority Critical patent/FR2193576B1/fr
Priority to CH638173A priority patent/CH572068A5/xx
Priority to PH7314601A priority patent/PH12351A/en
Priority to IL42250A priority patent/IL42250A/en
Priority to YU1278/73A priority patent/YU35037B/xx
Priority to CS3446A priority patent/CS165956B2/cs
Priority to FI731564A priority patent/FI52588C/fi
Priority to BE131184A priority patent/BE799615A/xx
Priority to SE7306996A priority patent/SE399711B/xx
Priority to ZA733340A priority patent/ZA733340B/xx
Priority to PL1973162627A priority patent/PL85506B1/pl
Priority to HURO730A priority patent/HU165993B/hu
Priority to DD170919A priority patent/DD104787A5/xx
Priority to SU1916475A priority patent/SU493961A3/ru
Priority to NL7306962A priority patent/NL7306962A/xx
Priority to ES414870A priority patent/ES414870A1/es
Priority to DE19732325358 priority patent/DE2325358C3/de
Priority to JP48054774A priority patent/JPS5212777B2/ja
Priority to NO2058/73A priority patent/NO138148C/no
Priority to CA171,864A priority patent/CA977746A/en
Priority to AU55900/73A priority patent/AU473292B2/en
Priority to EG186/73A priority patent/EG11080A/xx
Priority to IE811/73A priority patent/IE37657B1/xx
Priority to GB2401373A priority patent/GB1375357A/en
Priority to DK277473AA priority patent/DK133683B/da
Priority to AT441473A priority patent/AT325221B/de
Publication of FR2193576A1 publication Critical patent/FR2193576A1/fr
Application granted granted Critical
Publication of FR2193576B1 publication Critical patent/FR2193576B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FR7218035A 1972-05-19 1972-05-19 Expired FR2193576B1 (xx)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FR7218035A FR2193576B1 (xx) 1972-05-19 1972-05-19
CH638173A CH572068A5 (xx) 1972-05-19 1973-05-04
PH7314601A PH12351A (en) 1972-05-19 1973-05-10 Novel derivatives of 6 alpha-methyl-prednisolone
IL42250A IL42250A (en) 1972-05-19 1973-05-11 6alpha-methylprednisolone-21-metasulphobenzoate preparation process and pharmaceutical compositions
YU1278/73A YU35037B (en) 1972-05-19 1973-05-15 Process for preparing novel 6 delta-methylprednisolone derivatives
CS3446A CS165956B2 (xx) 1972-05-19 1973-05-15
FI731564A FI52588C (fi) 1972-05-19 1973-05-15 Tapa valmistaa farmakologisesti käyttökelpoista 6alfa-metyyliprednisol oni-21-m-sulfobentsoaatin litiumsuolaa.
BE131184A BE799615A (fr) 1972-05-19 1973-05-16 Nouveaux derives de la 6alpha-methylprednisolone
ZA733340A ZA733340B (en) 1972-05-19 1973-05-17 New 6alpha-methylprednisolone derivatives,preparation process and pharmaceutical compositions
PL1973162627A PL85506B1 (xx) 1972-05-19 1973-05-17
HURO730A HU165993B (xx) 1972-05-19 1973-05-17
SE7306996A SE399711B (sv) 1972-05-19 1973-05-17 Sett att framstella ett derivat av 6 alfa-metylprednisolon
DD170919A DD104787A5 (xx) 1972-05-19 1973-05-18
NL7306962A NL7306962A (xx) 1972-05-19 1973-05-18
ES414870A ES414870A1 (es) 1972-05-19 1973-05-18 Procedimiento de preparacion de nuevos derivados de la 6- alfa-metilprednisolona.
DE19732325358 DE2325358C3 (de) 1972-05-19 1973-05-18 Lithiumsalz des 6-alpha-Methylprednisolon-21-m-sulfobenzoats, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
JP48054774A JPS5212777B2 (xx) 1972-05-19 1973-05-18
NO2058/73A NO138148C (no) 1972-05-19 1973-05-18 Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon
CA171,864A CA977746A (en) 1972-05-19 1973-05-18 PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE LA 6.alpha.-METHYL PREDNISOLONE
AU55900/73A AU473292B2 (en) 1972-05-19 1973-05-18 6-methylprednisolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same
SU1916475A SU493961A3 (ru) 1972-05-19 1973-05-18 Способ получени производных 6 метилпреднизолона
EG186/73A EG11080A (en) 1972-05-19 1973-05-19 Derivatives of 6 methyl-prednisolone and processes for their preparation
IE811/73A IE37657B1 (en) 1972-05-19 1973-05-21 Derivatives of 6alpha-methyl-prednisolone processes for their preparation and compositions incorporating them
GB2401373A GB1375357A (xx) 1972-05-19 1973-05-21
DK277473AA DK133683B (da) 1972-05-19 1973-05-21 Analogifremgangsmåde til fremstilling af lithium-21-m-sulfobenzoat af 6alfa-methylprednisolon.
AT441473A AT325221B (de) 1972-05-19 1973-05-21 Verfahren zur herstellung neuer derivate des 6alpha-methylprednisolons

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7218035A FR2193576B1 (xx) 1972-05-19 1972-05-19

Publications (2)

Publication Number Publication Date
FR2193576A1 true FR2193576A1 (xx) 1974-02-22
FR2193576B1 FR2193576B1 (xx) 1975-08-08

Family

ID=9098837

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7218035A Expired FR2193576B1 (xx) 1972-05-19 1972-05-19

Country Status (25)

Country Link
JP (1) JPS5212777B2 (xx)
AT (1) AT325221B (xx)
AU (1) AU473292B2 (xx)
BE (1) BE799615A (xx)
CA (1) CA977746A (xx)
CH (1) CH572068A5 (xx)
CS (1) CS165956B2 (xx)
DD (1) DD104787A5 (xx)
DK (1) DK133683B (xx)
EG (1) EG11080A (xx)
ES (1) ES414870A1 (xx)
FI (1) FI52588C (xx)
FR (1) FR2193576B1 (xx)
GB (1) GB1375357A (xx)
HU (1) HU165993B (xx)
IE (1) IE37657B1 (xx)
IL (1) IL42250A (xx)
NL (1) NL7306962A (xx)
NO (1) NO138148C (xx)
PH (1) PH12351A (xx)
PL (1) PL85506B1 (xx)
SE (1) SE399711B (xx)
SU (1) SU493961A3 (xx)
YU (1) YU35037B (xx)
ZA (1) ZA733340B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112816A (ja) * 1975-04-03 1976-01-31 Wakao Kanao Tairubaripurekyasutokonkuriitono seizohoho
JPS51122118A (en) * 1975-04-15 1976-10-26 Wakao Kanao Production of tiled precast concrete
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US4948533A (en) * 1984-03-28 1990-08-14 The Upjohn Company 11a-hydroxy steroid diester

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DICTIONNAIRE VIDAL OFFICE DE VULGARISATION PHARMACEUTIQUE PARIS EDITION 1965.) *

Also Published As

Publication number Publication date
AU473292B2 (en) 1976-06-17
NL7306962A (xx) 1973-11-21
FR2193576B1 (xx) 1975-08-08
DD104787A5 (xx) 1974-03-20
DE2325358B2 (de) 1976-01-29
SU493961A3 (ru) 1975-11-28
FI52588B (xx) 1977-06-30
JPS4948653A (xx) 1974-05-11
JPS5212777B2 (xx) 1977-04-09
YU127873A (en) 1979-12-31
IL42250A0 (en) 1973-07-30
GB1375357A (xx) 1974-11-27
DE2325358A1 (de) 1973-11-29
DK133683C (xx) 1976-11-15
AT325221B (de) 1975-10-10
AU5590073A (en) 1974-11-21
DK133683B (da) 1976-06-28
NO138148B (no) 1978-04-03
IE37657L (en) 1973-11-19
IE37657B1 (en) 1977-09-14
CA977746A (en) 1975-11-11
PH12351A (en) 1979-01-29
CS165956B2 (xx) 1975-12-22
HU165993B (xx) 1974-12-28
IL42250A (en) 1977-06-30
BE799615A (fr) 1973-11-16
FI52588C (fi) 1977-10-10
ES414870A1 (es) 1976-05-01
CH572068A5 (xx) 1976-01-30
EG11080A (en) 1977-04-30
YU35037B (en) 1980-06-30
PL85506B1 (xx) 1976-04-30
SE399711B (sv) 1978-02-27
ZA733340B (en) 1974-11-27
NO138148C (no) 1978-07-12

Similar Documents

Publication Publication Date Title
FR2182143B1 (xx)
CS157532B1 (xx)
CS158596B2 (xx)
CS152715B1 (xx)
CS152940B1 (xx)
CS154135B1 (xx)
CS154994B1 (xx)
CS162969B1 (xx)
CS159051B1 (xx)
JPS4957947A (xx)
CS158470B1 (xx)
JPS4970140U (xx)
CS157368B1 (xx)
CS156198B1 (xx)
CS155580B1 (xx)
CH574188A5 (xx)
CH585106A5 (xx)
CH565883A5 (xx)
CH567667A5 (xx)
CH568438B5 (xx)
CH569642A5 (xx)
CH570521A5 (xx)
CH571648A5 (xx)
CH572824A5 (xx)
CH560355A5 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse